Utang agregat perusahaan: Predictive Oncology Inc (POAI)

Predictive Oncology creates an AI environment for personalized cancer therapy selection. Total credit obligations visualize the financial burden, where the latest mark stands at 0.00. The stability of 3D modeling system deliveries guarantees order fulfillment. Growth in B2B subscriptions and the development of the CoRE platform accelerate the discovery of new drugs, ensuring the company's sustainable development in the medtech market.

Stable rental income for Predictive Oncology (POAI) from long-term contracts with pharma behemoths allows the company to minimize its reliance on external financing. This metric aggregates all current obligations in real-time, reflecting the actual debt load and the cost of borrowed capital; therefore, analyzing the volume of borrowed funds helps investors assess the balance between financial stability and the pace of business scaling.